A new oral antiviral drug from Pfizer has now approved emergency authorization on Wednesday, 22/12/2021. This medication is recommended to high risk patients, and it's said to be available within the week. It has been approved for patients above 12 years old, with mild to moderate Covid-19 symptoms and should be prescribed as soon as possible after diagnosis, and within 5 days.

The rollout of this new tool against Covid-19, is coming at a crucial point of the pandemic, with the new Omicron variant being now the dominant strain, while along with the approved vaccines, the condition should gradually improve.


Source:
https://www.cnbc.com/2021/12/22/fda-authorizes-pfizers-covid-treatment-pill-the-first-oral-antiviral-drug-cleared-during-the-pandemic.html